BUOY
LIVE

Serial Number

90323594

Owner

Source Donor Inc.

Attorney

DARREN M. GELIEBTER

Filing Date

Nov 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BUOY Trademark

Serial Number: 90323594

BUOY is a trademark filed by Source Donor Inc. on November 17, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Source Donor Inc. (14 trademarks)

767 5th Avenue, Floor 15
New York, NY 10153

Entity Type: 03

Trademark Details

Filing Date

November 17, 2020

Registration Date

Not Registered

Published for Opposition

December 7, 2021

Goods & Services

Licensing of software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; white label software services, namely, licensing of computer software platform to blood plasma donation and collection centers for use in association with their own branding; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers

Software as a service (SAAS) services featuring software for operating, administering and managing blood plasma collection and donation centers, and the associated compensation and incentive reward programs administered therewith; Software development for use in connection with operating, administering and managing of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Mobile application software development for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Application service provider featuring application programming interface (API) software and on-line, non-downloadable software development tools for use in operating, administering and managing of blood plasma donation and collection centers and the associated compensation and incentive reward programs administered therewith; platform as a service (PAAS) featuring application programming interface (API) software and on-line, non-downloadable software development tools for operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Consultancy relating to computer software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Software subscription, namely, rental of computer software for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; leasing and customizing white label software platform for use by blood plasma donation and collection centers; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers

Electronic data collection, data processing, and data analysis, all of the foregoing for business purposes, namely, for use in connection with the collection, screening, testing, transport, distribution, and storage of human blood plasma; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers

Filing History

SOU TEAS EXTENSION RECEIVED
Mar 5, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 5, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 5, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 3, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 3, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EXRA
SOU EXTENSION 2 GRANTED
Aug 27, 2024 EX2G
SOU EXTENSION 2 FILED
Aug 27, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 29, 2024 EX1G
SOU EXTENSION 1 FILED
Feb 29, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 29, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jul 26, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
Jul 26, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Jul 26, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
Jun 3, 2022 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 16, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 30, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2021 NWOS
NEW APPLICATION ENTERED
Nov 20, 2020 NWAP